D Schenk

Kunitz Protease Inhibitor‐Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease

B T Hyman, B. Hyman, R. Tanzi, 1992, Journal of neuropathology and experimental neurology.

A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.

M McNamara, B T Hyman, B. Hyman, 1997, Annals of neurology.

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

J. Kaye, D. Knopman, D. Galasko, 1998, Archives of neurology.